Last Update 25 Jun 26
Fair value Increased 2.65%ACKB: Future Returns Will Reflect Higher Multiple And Adjusted Profitability Assumptions
Analysts have raised their Ackermans & Van Haaren price target slightly to about €304 from roughly €296. This reflects updated assumptions on the discount rate, profit margin and future P/E that together indicate a modestly higher fair value estimate.
What’s in the News for Ackermans & Van Haaren
- No recent company specific news items for Ackermans & Van Haaren were provided in the available sources.
- No periodical coverage related to Ackermans & Van Haaren was supplied in the secondary sources.
- No key corporate developments, such as transactions, guidance updates or management changes, were included in the data reviewed.
Valuation Changes
- The fair value estimate for Ackermans & Van Haaren has risen slightly from about €296.29 to roughly €304.14, implying a modestly higher assessed level.
- The discount rate has edged lower from around 9.14% to about 9.08%, reflecting a small reduction in the required return assumption.
- The revenue growth assumption is effectively unchanged at about 2.45% in both the previous and updated models.
- The net profit margin has been adjusted from roughly 10.89% to about 10.50%, representing a small reduction in the projected profitability level.
- The future P/E has been lifted from about 17.66x to roughly 18.76x, indicating a slightly higher multiple applied to Ackermans & Van Haaren in the updated assessment.
Key Takeaways
- Strong growth and collaboration in financial services suggest sustained revenue increases and enhanced banking operations.
- Strategic investments and financial flexibility position for diversified revenue streams and potential earnings growth.
- Heavy reliance on specific subsidiaries poses concentration risk, while external growth and new investments carry execution and integration challenges, impacting future financial performance.
Catalysts
About Ackermans & Van Haaren- Engages in marine engineering and contracting, private banking, real estate and senior care, energy and resources, and AvH & Growth Capital businesses worldwide.
- The strong growth and record results achieved by Delen Private Bank and Bank Van Breda, with net inflows and synergetic collaboration, signal continued future revenue growth from financial services.
- DEME's record turnover and solid free cash flow generation, paired with reduced net financial debt, set the stage for improved net margins and earnings from enhanced operational efficiency and financial flexibility.
- The renewed and extended partnership with the Delen family indicates strengthened client relationships and potential for future revenue increases and net margin improvements in banking operations.
- Strategic investments, such as those in V. Group and Confo Therapeutics, point towards diversified future revenue streams and potential earnings growth from these sectors.
- The current net cash position of €362 million provides opportunities for further investments, likely leading to future revenue growth and potentially higher earnings through strategic acquisitions and financial growth initiatives.
Ackermans & Van Haaren Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Ackermans & Van Haaren's revenue will grow by 2.5% annually over the next 3 years.
- Analysts assume that profit margins will increase from 9.9% today to 10.5% in 3 years time.
- Analysts expect earnings to reach €673.3 million (and earnings per share of €21.3) by about June 2029, up from €592.5 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as €784.7 million.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 19.0x on those 2029 earnings, up from 15.8x today. This future PE is greater than the current PE for the GB Construction industry at 13.2x.
- Analysts expect the number of shares outstanding to decline by 0.25% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 9.08%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Heavy reliance on specific subsidiaries like Delen Private Bank, Bank Van Breda, and DEME for growth could pose a concentration risk, potentially impacting revenue and earnings if these entities face downturns.
- Recent investments in new sectors and companies, such as V. Group and Confo Therapeutics, may encounter integration challenges or fail to achieve expected returns, impacting net margins.
- Continued investments, despite strong free cash flow, require efficient capital allocation; missteps could strain financial resources, affecting future earnings and profitability.
- While current cash positions are strong, economic downturns or unexpected market challenges could deplete cash reserves, impacting the company's ability to invest and sustain growth.
- External growth initiatives, though promising, carry execution risks, and any failure in execution might hinder expected revenue growth, impacting overall financial performance.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of €304.14 for Ackermans & Van Haaren based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €340.0, and the most bearish reporting a price target of just €255.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €6.4 billion, earnings will come to €673.3 million, and it would be trading on a PE ratio of 19.0x, assuming you use a discount rate of 9.1%.
- Given the current share price of €286.0, the analyst price target of €304.14 is 6.0% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Ackermans & Van Haaren?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.